menu
    • menu

    Company profile for Larkspur Biosciences

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Larkspur was founded to develop precision immunotherapies targeting the key intersection between the tumor and the immune system. Our science is based on discoveries by our founders that the genetic deficiency of specific targets leads to autoimmunity – a hallmark of targets that are important for cancer immunotherapy. With a proven track record of drug discovery and development, our team is passionate about solving hard pro...
    Larkspur was founded to develop precision immunotherapies targeting the key intersection between the tumor and the immune system. Our science is based on discoveries by our founders that the genetic deficiency of specific targets leads to autoimmunity – a hallmark of targets that are important for cancer immunotherapy. With a proven track record of drug discovery and development, our team is passionate about solving hard problems and driven to deliver new medicines to cancer patients with significant unmet needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Larkspur BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    480 Arsenal Way, Suite 125, Watertown, MA 02472
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://larkspur.bio/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Larkspur Biosciences Begins Dosing LRK-4189 in Clinical Study
    Larkspur Biosciences Begins Dosing LRK-4189 in Clinical Study

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198723/0/en/Larkspur-Biosciences-Begins-Dosing-in-Clinical-Study-of-LRK-4189-a-First-in-Class-Targeted-Protein-Degrader.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Larkspur Bio Unveils LRK-4189 for MSS Colorectal Cancer Treatment
    Larkspur Bio Unveils LRK-4189 for MSS Colorectal Cancer Treatment

    20 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/20/3136744/0/en/Larkspur-Biosciences-Announces-Discovery-of-LRK-4189-a-First-in-Class-Degrader-of-the-Lipid-Kinase-PIP4K2C-for-the-Treatment-of-Microsatellite-Stable-MSS-Colorectal-Cancer-at-the-A.html

    GLOBENEWSWIRE
    20 Aug 2025
    Share Share
    Larkspur to Present New Preclinical R&D Program Candidate at AACR 2024
    Larkspur to Present New Preclinical R&D Program Candidate at AACR 2024

    28 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/28/2853926/0/en/Larkspur-Biosciences-to-Present-New-Preclinical-Research-on-Lead-Development-Program-Candidate-a-First-in-Class-PIP4K2C-Protein-Degrader-at-AACR-2024.html

    GLOBENEWSWIRE
    28 Mar 2024
    Share Share
    Larkspur Bio Announces CEO Catherine Sabatos-Peyton to Participate in Events
    Larkspur Bio Announces CEO Catherine Sabatos-Peyton to Participate in Events

    14 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/14/2796189/0/en/Larkspur-Biosciences-Announces-CEO-Catherine-Sabatos-Peyton-to-Participate-in-Upcoming-Biotech-Events.html

    GLOBENEWSWIRE
    14 Dec 2023
    Share Share
    Larkspur to Present Data on Role of Pin1 in Fibroblast Cancer Axis
    Larkspur to Present Data on Role of Pin1 in Fibroblast Cancer Axis

    25 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/25/2766424/0/en/Larkspur-Biosciences-to-Present-New-Mechanistic-Data-on-the-Role-of-Pin1-in-Modulating-the-Fibroblast-Cancer-Axis-at-SITC-2023.html

    GLOBENEWSWIRE
    25 Oct 2023
    Share Share
    Larkspur Announces First-in-Class Program Targeting Novel B Cell Checkpoint
    Larkspur Announces First-in-Class Program Targeting Novel B Cell Checkpoint

    26 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/26/2694292/0/en/Larkspur-Biosciences-Announces-First-in-Class-Program-Targeting-Novel-B-Cell-Checkpoint.html

    GLOBENEWSWIRE
    26 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search